Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Dec 4;16(12):e75108.
doi: 10.7759/cureus.75108. eCollection 2024 Dec.

Assessment of Knowledge, Practices, and Attitudes Toward Prostate Cancer and Its Screening Among Men Aged 40 Years and Older in the United Arab Emirates: A Cross-Sectional Study

Affiliations

Assessment of Knowledge, Practices, and Attitudes Toward Prostate Cancer and Its Screening Among Men Aged 40 Years and Older in the United Arab Emirates: A Cross-Sectional Study

Mahmoud Eladl et al. Cureus. .

Abstract

Introduction: Prostate cancer is the second most common cancer in men globally and the fifth greatest cause of cancer-related mortality. In the United Arab Emirates (UAE), prostate cancer has been on the rise due to population aging. However, knowledge deficits and screening barriers do exist because of cultural, social, and psychological factors. The objective of this study is to assess the knowledge, practices, and attitudes of prostate cancer and its screening among men aged 40 years and above in the UAE.

Methodology: A cross-sectional study was conducted between September 5 and October 31, 2024, using a self-administered online questionnaire distributed through social media platforms. Data collected from the questionnaire were analyzed using SPSS version 26 (IBM Corp., Armonk, NY).

Results: A total of 471 responses were analyzed. The median age of participants was 51 ± 12. Most of the respondents were non-healthcare workers with at least a bachelor's degree. Most of the participants were moderately aware of prostate cancer risk factors and symptoms. However, there was a severe lack of awareness of genetic predisposition and racial risk factors. While 80.3% of participants were aware of the role of prostate-specific antigen test in prostate screening, 62.8% recognize the role of a digital rectal examination. The most important barriers to screening were lack of perceived risk, time constraint, and fear of diagnosis.

Conclusion: Significant knowledge gaps and barriers to prostate screening exist. Health education initiatives targeting cultural stigma with the use of culturally appropriate and accurate information through credible online platforms are necessary.

Keywords: male health awareness; prostate cancer; psa; screening; uae.

PubMed Disclaimer

Conflict of interest statement

Human subjects: Consent for treatment and open access publication was obtained or waived by all participants in this study. Research Ethics Committee of the Medical Colleges at the University of Sharjah issued approval REC-24-06-11-01-F. Animal subjects: All authors have confirmed that this study did not involve animal subjects or tissue. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.

Figures

Figure 1
Figure 1. Participants' knowledge of prostate cancer symptoms
The data has been represented as n (%)
Figure 2
Figure 2. Sources of information on PSA
The data has been represented as n (%) PSA: prostate-specific antigen

Similar articles

Cited by

References

    1. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. CA Cancer J Clin. 2021;71:209–249. - PubMed
    1. Prostate cancer review: genetics, diagnosis, treatment options, and alternative approaches. Sekhoacha M, Riet K, Motloung P, Gumenku L, Adegoke A, Mashele S. Molecules. 2022;27:5730. - PMC - PubMed
    1. Burden of prostate cancer in the Middle East: a comparative analysis based on global cancer observatory data. Kearney G, Chen MH, Mula-Hussain L, et al. Cancer Med. 2023;12:21419–21425. - PMC - PubMed
    1. Harbi AZ, Belaila BAB, Shelpai W, Razzak HA. Cancer Care in the United Arab Emirates. Singapore: Springer Nature; 2024. UAE national cancer registry.
    1. Prostate cancer screening: continued controversies and novel biomarker advancements. Tidd-Johnson A, Sebastian SA, Co EL, et al. Curr Urol. 2022;16:197–206. - PMC - PubMed

LinkOut - more resources